A new report from Santander and the manufacturers’ organisation, EEF, has highlighted five key areas for growth in the UK’s pharmaceutical sector.
Market research
Identified as primary growth opportunities in the report were personalised medicines, technology, accelerated access pathway, an ageing population and demand from emerging markets: